Covered recipient · General Payments record
STEPHANIE J RICHARDS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,553.39
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.66 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $176.56 | 3 |
| Novo Nordisk AS | $83.58 | 4 |
| E.R. Squibb & Sons, L.L.C. | $24.18 | 1 |
| GlaxoSmithKline, LLC. | $21.31 | 1 |
| Lilly USA, LLC | $18.79 | 1 |
| ABBVIE INC. | $17.08 | 1 |
| Amgen Inc. | $17.02 | 1 |
| PFIZER INC. | $17.01 | 1 |
| Lundbeck LLC | $16.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.08 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945053 | CMS |
| Amgen Inc. | $17.02 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116056027 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.62 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105687351 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.76 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104229981 | CMS |
| AstraZeneca Pharmaceuticals LP | $123.18 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104449091 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24.18 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101570182 | CMS |
| GlaxoSmithKline, LLC. | $21.31 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116524320 | CMS |
| Lilly USA, LLC | $18.79 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135386471 | CMS |
| Lundbeck LLC | $16.13 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145961198 | CMS |
| Novo Nordisk Inc | $21.47 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096590361 | CMS |
| Novo Nordisk Inc | $19.91 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096620544 | CMS |
| Novo Nordisk Inc | $19.07 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097260938 | CMS |
| Novo Nordisk Inc | $23.13 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097402367 | CMS |
| PFIZER INC. | $17.01 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130894578 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.